Laparoscopic Surgery: Comparison of Conventional Trocars to the Teleflex® MiniLap® System
MiniTroc
Benign Gynecologic Laparoscopic Surgery: Comparison of Conventional Trocars to the Teleflex® MiniLap® System in Length of Hospitalization, Pain and Aesthetics, a Randomized Study.
2 other identifiers
interventional
50
1 country
1
Brief Summary
During laparoscopy, trocars are essential: they allow the passage of instruments through the wall. In gynecology, with exception, trocars 5mm (used for the passage of endo-scissors and forceps) and 10 to 12mm are used (especially for optics). Trocars are responsible for complications, such as vascular wounds, digestive wounds, pain, infections or postoperative hernias, or aesthetic sequelae, and should be chosen with caution: most complications of laparoscopy are essentially due to their placement, and the complications at the introduction of the first trocar are the most frequent. The MiniLap® system developed by Teleflex does not require trocars in the case of a single forceps, or a single 5mm trocar with the necessary forceps change (this is the Percuvance® system). The aim of the latter is to make minimally invasive surgery even less invasive, thanks to a reduction in the number of trocars used (in many cases, elimination of two trocars), smaller incisions (percutaneous use of instruments, with a diameter of 2,4mm) thus reducing the complications
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2019
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 29, 2018
CompletedFirst Posted
Study publicly available on registry
October 31, 2018
CompletedStudy Start
First participant enrolled
January 15, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 27, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
April 27, 2021
CompletedApril 29, 2021
April 1, 2021
2.3 years
October 29, 2018
April 28, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The time required to validate the Marshall and Chung criteria authorizing outpatient discharge when using the Minilap® system in comparison to the use of conventional trocars.
at the end of surgery, an average 3 hours
Secondary Outcomes (5)
Pain using the Visual Analog Scale (VAS)
at immediate postoperative (baseline,1 hour and 3 hours) and postoperative visit (6 weeks ± 1 after surgery).
Aesthetic scars using a scale of 0 to 10
postoperative visit (6 weeks ± 1 after surgery).
number of complication per operative
At immediate postoperative (baseline,1 hour and 3 hours)
of the intraoperative use of the trocar system using a questionnaire to be completed by the surgeon
At immediate postoperative (baseline,1 hour and 3 hours)
post-operative complications at the level of the trocar apertures using a questionnaire
at immediate postoperative (baseline,1 hour and 3 hours) and postoperative visit (6 weeks ± 1 after surgery).
Study Arms (2)
trocars of type MiniLap
EXPERIMENTALPatients benefiting from the use of trocars of type MiniLap of Teleflex during the realization of their coelioscopy scheduled in ambulatory
trocars classics
ACTIVE COMPARATORPatients benefiting from the use of trocats classics during the realization of their coelioscopy scheduled(programmed) in ambulatory.
Interventions
Subjects participating in the study will undergo laparoscopic gynecologic surgery as planned in the routine care, but using the MiniLap System instead of the conventional single-use trocars used usually.
Subjects participating in the study will undergo laparoscopic gynecologic surgery as planned in the routine care using the conventional single-use trocars used usually.
Eligibility Criteria
You may qualify if:
- BMI \<35kg / m2
- No history of multiple abdominopelvic surgery
- Without absolute contraindication to laparoscopy
- In the context of ambulatory surgery
- With precise laparoscopy of indication:
- Exploratory or diagnostic
- Exploration of infertility
- Performing a tubal permeability test
- Performing a salpingectomy
- Realization of a tubal sterilization
- Realization of a tubal plasty
- Performing an ovariectomy
- Performing a simple ovarian cystectomy
- Patient have been informed during her preoperative consultation and have signed the consent in a free and informed manner upon admission to hospital
You may not qualify if:
- Performing an emergency surgery
- Carcinological surgery
- Performing a benign but complex surgery such as:
- Hysterectomy
- Prolapse cure
- promontofixation
- Complex surgery of endometriosis
- Removal of large cyst from the ovary.
- Person unable to receive informed information and / or give consent. Person deprived of liberty.
- Pregnant or nursing woman.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University Hospital, Lillelead
- Teleflexcollaborator
Study Sites (1)
Hôpital Jeanne de Flandres, CHU
Lille, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Chrystelle Rubod, MD,PhD
University Hospital, Lille
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 29, 2018
First Posted
October 31, 2018
Study Start
January 15, 2019
Primary Completion
April 27, 2021
Study Completion
April 27, 2021
Last Updated
April 29, 2021
Record last verified: 2021-04